HDFC Innovation Fund vs HDFC Pharma and Healthcare Fund

Portfolio Overlap Analysis · HDFC vs HDFC

19.8%
Low Overlap
11 common stocks · Rank #11158 of 28,282 pairs
Fund A
HDFC Innovation Fund
HDFC · Equity - Other
Fund B
HDFC Pharma and Healthcare Fund
HDFC · Sectoral - Pharma

Common Holdings (10)

StockWt% in HDFC InnovationWt% in HDFC Pharma and HealthcareOverlap
Divis Laboratories Ltd.
Pharmaceuticals & Biotechnology
4.33%8.38%4.33%
Sun Pharmaceutical Industries Ltd.
Pharmaceuticals & Biotechnology
2.56%9.81%2.56%
Torrent Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
2.66%2.34%2.34%
Laurus Labs Ltd.
Pharmaceuticals & Biotechnology
2.09%2.91%2.09%
Sai Life Sciences Limited
Pharmaceuticals & Biotechnology
1.61%2.09%1.61%
Anthem Biosciences Limited
Pharmaceuticals & Biotechnology
1.30%4.46%1.30%
Lupin Ltd.
Pharmaceuticals & Biotechnology
1.26%6.44%1.26%
Ipca Laboratories Ltd.
Pharmaceuticals & Biotechnology
1.25%4.80%1.25%
Rubicon Research Limited
Pharmaceuticals & Biotechnology
1.50%1.22%1.22%
Thyrocare Technologies Ltd.
Healthcare Services
1.09%1.39%1.09%

Unique to HDFC Innovation

  • Eternal Limited8.98%
  • Bajaj Finance Ltd.5.12%
  • Bharat Electronics Ltd.4.38%
  • PB Fintech Limited4.25%
  • Mahindra & Mahindra Ltd.3.72%
  • Reliance Industries Ltd.3.42%
  • INFO EDGE (INDIA) LIMITED2.83%
  • LENSKART SOLUTIONS LIMITED2.60%

Unique to HDFC Pharma and Healthcare

  • Glenmark Pharmaceuticals Ltd.6.62%
  • Max Healthcare Institute Limited6.36%
  • Alkem Laboratories Ltd.6.21%
  • Aster DM Healthcare Limited5.42%
  • Fortis Healthcare Limited4.02%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
18.7% (10)
Healthcare Services
1.1% (1)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for HDFC Innovation

More comparisons for HDFC Pharma and Healthcare

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.